A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Pall Corporation and Single Use Support Partner to Safeguard Storage and Transport Critical Biopharmaceuticals

December 16, 2020

Pall Corporation, a global leader in filtration, separation, and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill-finish.

Pall Corporation will provide significant investment and partner with Single Use Support to distribute the RoSS platform which enhances Pall’s integrated solutions and will make the RoSS platform more accessible to Biopharma customers around the globe.

“Safe and reliable management of drug substances is a challenge for many Pall customers. Through our partnership with Single Use Support, Pall will be able to offer the Biopharma industry a fully validated end-to-end solution, which will enable our customers to bring life-saving drugs to the patient in a more efficient way,” explained Ed Hoare, Vice President and General Manager, Pall Corporation.

Single-Use Support’s RoSS platform consists of an innovative workflow solution, combining robust RoSS shells to protect single-use biocontainers, such as Pall’s Allegro™ biocontainer bags, throughout the process with systems allowing automated filling, controlled freezing/thawing and safe transportation.

“Through high-value liquid management systems, we help our customers safeguard a step that, while inefficient, is mission-critical in bioprocessing,” said Johannes Kirchmair, co-founder and Managing Director of Single Use Support.

Thomas Wurm, co-founder and Managing Director of Single Use Support further explained, “Pall is a global science and technology innovator and shares our mission to help customers solve complex challenges to improve quality of life around the world. Pall Corporation holds an unparalleled leadership position in bioprocessing technologies. Through our partnership, our innovative solution will become more accessible to customers worldwide.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy